Trade Applied Therapeutics Inc - APLT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0504 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 50.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.438 |
Open | 0.39 |
1-Year Change | -93.9% |
Day's Range | 0.3818 - 0.405 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 2, 2025 | 0.4380 | 0.0185 | 4.41% | 0.4195 | 0.4393 | 0.4126 |
Apr 1, 2025 | 0.4418 | -0.0305 | -6.46% | 0.4723 | 0.4739 | 0.4380 |
Mar 31, 2025 | 0.4648 | 0.0198 | 4.45% | 0.4450 | 0.4926 | 0.4450 |
Mar 28, 2025 | 0.4922 | -0.0278 | -5.35% | 0.5200 | 0.5266 | 0.4884 |
Mar 27, 2025 | 0.5208 | 0.0108 | 2.12% | 0.5100 | 0.5317 | 0.5066 |
Mar 26, 2025 | 0.5011 | -0.0179 | -3.45% | 0.5190 | 0.5301 | 0.5011 |
Mar 25, 2025 | 0.5262 | -0.0098 | -1.83% | 0.5360 | 0.5360 | 0.5067 |
Mar 24, 2025 | 0.5345 | -0.0066 | -1.22% | 0.5411 | 0.5574 | 0.5202 |
Mar 21, 2025 | 0.5300 | 0.0602 | 12.81% | 0.4698 | 0.5841 | 0.4612 |
Mar 20, 2025 | 0.4780 | -0.0021 | -0.44% | 0.4801 | 0.4900 | 0.4671 |
Mar 19, 2025 | 0.4764 | -0.0136 | -2.78% | 0.4900 | 0.5002 | 0.4763 |
Mar 18, 2025 | 0.4974 | -0.0325 | -6.13% | 0.5299 | 0.5299 | 0.4788 |
Mar 17, 2025 | 0.5190 | 0.0309 | 6.33% | 0.4881 | 0.5240 | 0.4793 |
Mar 14, 2025 | 0.4863 | 0.0063 | 1.31% | 0.4800 | 0.5284 | 0.4749 |
Mar 13, 2025 | 0.4731 | -0.0173 | -3.53% | 0.4904 | 0.5040 | 0.4683 |
Mar 12, 2025 | 0.4928 | -0.0212 | -4.12% | 0.5140 | 0.5701 | 0.4686 |
Mar 11, 2025 | 0.5112 | 0.0249 | 5.12% | 0.4863 | 0.5242 | 0.4850 |
Mar 10, 2025 | 0.4848 | -0.0322 | -6.23% | 0.5170 | 0.5208 | 0.4769 |
Mar 7, 2025 | 0.5400 | 0.0725 | 15.51% | 0.4675 | 0.5719 | 0.4675 |
Mar 6, 2025 | 0.4771 | 0.0191 | 4.17% | 0.4580 | 0.4813 | 0.4418 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Applied Therapeutics, Inc. Company profile
About Applied Therapeutics Inc
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. The Company’s molecular target is aldose reductase (AR), an enzyme that converts glucose to sorbitol under oxidative stress conditions. Its product candidates include AT-007, AT-001, AT-003 and AT-104. The Company’s AT-007 is a central nervous system (CNS) penetrant ARI, which is developed for the treatment of galactosemia. AT-001 is an aldose reductase inhibitor (ARI) with exposure and nerve permeability. AT-001 is developed for the treatment of diabetic cardiomyopathy (DbCM), fatal fibrosis of the heart. Its AT-003 is an ARI designed to cross through the back of the eye when dosed orally. AT-003 is developed for the treatment of diabetic retinopathy (DR). AT-104 is a dual selective PI3K inhibitor in preclinical development for T Cell Acute Lymphoblastic Leukemia (T-ALL).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Applied Therapeutics Inc revenues was not reported. Net loss increased 12% to $105.6M. Higher net loss reflects General and administrative - Balancing increase of 66% to $15.7M (expense), Stock-based Compensation in SGA increase of 55% to $8.4M (expense), Other general & administrative expenses increase of 73% to $5.4M (expense).
Industry: | Bio Therapeutic Drugs |
545 5Th Avenue, Suite 1400
NEW YORK
NEW YORK 10017
US
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com